首页> 外文期刊>Familial cancer >Cancer risk and overall survival in mismatch repair proficient hereditary non-polyposis colorectal cancer, Lynch syndrome and sporadic colorectal cancer
【24h】

Cancer risk and overall survival in mismatch repair proficient hereditary non-polyposis colorectal cancer, Lynch syndrome and sporadic colorectal cancer

机译:错配修复熟练的遗传性非息肉性结直肠癌,林奇综合征和散发性结直肠癌的癌症风险和总体生存率

获取原文
获取原文并翻译 | 示例
       

摘要

Mismatch repair proficient hereditary non-polyposis colorectal cancer (MSS-HNPCC) encloses a heterogeneous group of families consisting of different unknown genetic syndromes and/or aggregations cases. The lack of information about the hereditability of cancer risk in these families makes it difficult to carry out an individualized Genetic Counseling. Therefore, deep description of such families becomes important for a better classification and search for underlying susceptibility causes. The aim of this study is to describe and compare the clinical, morphological features, tumor KRAS status and overall survival in MSS-HNPCC, Lynch and sporadic colorectal cancer. A total of 37 MSS-HNPCC families, 50 Lynch families and 612 sporadic CRC were included. Clinical and morphological data were evaluated by reviewing medical and pathology reports of 55, 69 and 102 tumors respectively. KRAS/BRAF status were detected by allele specific real-time PCR. Standardized incidence ratios (SIR) were calculated among 602 MSS-HNPCC relatives and 668 Lynch relatives. Main features distinguishing MSS-HNPCC were diagnosis age (55.1 ± 12.6), preferential distal location (76 %), polyp detection (45 %) and familial colorectal cancer incidence (SIR = 6.6). In addition, we found increased incidences rates for kidney, stomach and uterus tumors. KRAS mutation rates were similar in the study populations (48.8 ± 5.8) but higher than those described before by Sanger sequencing. MSS-HNPCC overall survival was similar to Lynch in B Dukes' stage tumors and between Lynch and sporadic in C stage tumors. Anatomical and morphological data of MSS-HNPCC are consistent with other described populations. Our studies disclose an increased HNPCC-extracolonic tumors incidence and improved overall survival in MSS-HNPCC families.
机译:错配修复能力强的遗传性非息肉性结直肠癌(MSS-HNPCC)围成一个由不同的未知遗传综合征和/或聚集病例组成的异族家庭。这些家庭中缺乏关于癌症风险可遗传性的信息,这使得开展个性化的遗传咨询变得困难。因此,对此类家族的深入描述对于更好的分类和寻找潜在的易感性原因变得很重要。这项研究的目的是描述和比较MSS-HNPCC,Lynch和散发性结直肠癌的临床,形态特征,肿瘤KRAS状态和总生存期。总共包括37个MSS-HNPCC家族,50个林奇家族和612个散发性CRC。通过分别审查55、69和102个肿瘤的医学和病理报告来评估临床和形态学数据。通过等位基因特异性实时PCR检测KRAS / BRAF状态。计算了602名MSS-HNPCC亲属和668名Lynch亲属中的标准发病率(SIR)。 MSS-HNPCC的主要特征是诊断年龄(55.1±12.6),远端位置优先(76%),息肉检出(45%)和家族性大肠癌发生率(SIR = 6.6)。此外,我们发现肾,胃和子宫肿瘤的发病率增加。在研究人群中,KRAS突变率相似(48.8±5.8),但高于之前由Sanger测序所描述的突变率。 MSS-HNPCC的总体生存率在B Dukes期肿瘤中与Lynch相似,而在C期肿瘤中则与Lynch和偶发性相似。 MSS-HNPCC的解剖学和形态学数据与其他描述的种群一致。我们的研究表明,MSS-HNPCC家庭中HNPCC-结肠外肿瘤的发病率增加,总生存期提高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号